Bell Investment Advisors’s Akero Therapeutics AKRO Stock Holding History

Bell Investment Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-39	Closed	-$1.85K	–	1806
2025 Q3	$1.85K	Hold	39	–	–	﹤0.01%	1358
2025 Q2	$2.08K	Buy	39 +28	+255%	+$1.27K	﹤0.01%	1352
2025 Q1	$446	Buy	+11	New	+$466	﹤0.01%	1797
2023 Q4	–	Sell	-11	Closed	-$557	–	1911
2023 Q3	$557	Buy	+11	New	+$512	﹤0.01%	1749

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bell Investment Advisors's AKRO Position: Q4 2025 in Review

Bell Investment Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 39 shares — an estimated $1.85K sold.

Bell Investment Advisors first reported a position in AKRO in Q3 2023 and held it in 4 quarters. The position peaked at $2.08K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Bell Investment Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Bell Investment Advisors sold 39 Akero Therapeutics shares in Q4 2025, an estimated $1.85K.
Bell Investment Advisors first reported a position in Akero Therapeutics in Q3 2023 and held it in 4 quarters.
Bell Investment Advisors's Akero Therapeutics position peaked at $2.08K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Bell Investment Advisors's 13F filing for Q4 2025, filed 24 Feb 2026.